Aim: This work studied the impact of the quorum-sensing molecule, farnesol (FAR), on fluconazole (FLC)-resistant Candida albicans isolate CY 1123 compared with the susceptible standard strain C. albicans SC5314. The genes encoding efflux pumps belonging to the ATP-binding cassette (ABC) and major facilitator superfamilies, together with overexpression or point mutation of the ERG11 gene, are the main resistance mechanisms to azole antifungal drugs. Results: The upregulation of genes coding for CDR1, CDR2, and MDR1 were confirmed by qPCR with respect to the housekeeping gene ACT1 in the resistant strain. The contribution of the ERG11 gene was also observed. Markedly, increased pump activity (Cdr1 and/or Cdr2) in the CY 1123 strain was confirmed using diS-C3(3) assay. However, the addition of FAR to the yeasts diminished the difference in staining levels between the SC5314 and CY 1123 strains, demonstrating the concentration-dependent character that could be caused by an effective modulation of Cdr pumps. FAR (60 and 100 μM) was also able to decrease the minimal inhibitory concentrations (MIC50), denoting the inhibition of planktonic cells by 50%, from 8 to 4 μg/mL of FLC when the resistant strain CY 1123 was not cultivated with FLC. However, when it was exposed to 64 μg/mL of FLC, the MIC50 shifted from 64 to 8 μg/mL. Conclusion: Besides the many other effects of FAR on eukaryotic and prokaryotic cells, it also affects ABC efflux transporters, resulting in changes in resistance to azoles in C. albicans isolates. However, this effect is dependent on FAR concentrations.

Department of Microbiology and Virology Faculty of Natural Sciences Comenius University in Bratislava Bratislava Slovakia

Faculty of Mathematics and Physics Institute of Physics Charles University Prague Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc19044983

003      

CZ-PrNML

005      

20200115131350.0

007      

ta

008      

200109s2019 xxu f 000 0|eng||

009      

AR

024    7_

$a 10.1089/mdr.2017.0332 $2 doi

035    __

$a (PubMed)30785845

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxu

100    1_

$a Černáková, Lucia $u 1 Department of Microbiology and Virology, Faculty of Natural Sciences, Comenius University in Bratislava, Bratislava, Slovakia.

245    10

$a Impact of Farnesol as a Modulator of Efflux Pumps in a Fluconazole-Resistant Strain of Candida albicans / $c L. Černáková, S. Dižová, D. Gášková, I. Jančíková, H. Bujdáková,

520    9_

$a Aim: This work studied the impact of the quorum-sensing molecule, farnesol (FAR), on fluconazole (FLC)-resistant Candida albicans isolate CY 1123 compared with the susceptible standard strain C. albicans SC5314. The genes encoding efflux pumps belonging to the ATP-binding cassette (ABC) and major facilitator superfamilies, together with overexpression or point mutation of the ERG11 gene, are the main resistance mechanisms to azole antifungal drugs. Results: The upregulation of genes coding for CDR1, CDR2, and MDR1 were confirmed by qPCR with respect to the housekeeping gene ACT1 in the resistant strain. The contribution of the ERG11 gene was also observed. Markedly, increased pump activity (Cdr1 and/or Cdr2) in the CY 1123 strain was confirmed using diS-C3(3) assay. However, the addition of FAR to the yeasts diminished the difference in staining levels between the SC5314 and CY 1123 strains, demonstrating the concentration-dependent character that could be caused by an effective modulation of Cdr pumps. FAR (60 and 100 μM) was also able to decrease the minimal inhibitory concentrations (MIC50), denoting the inhibition of planktonic cells by 50%, from 8 to 4 μg/mL of FLC when the resistant strain CY 1123 was not cultivated with FLC. However, when it was exposed to 64 μg/mL of FLC, the MIC50 shifted from 64 to 8 μg/mL. Conclusion: Besides the many other effects of FAR on eukaryotic and prokaryotic cells, it also affects ABC efflux transporters, resulting in changes in resistance to azoles in C. albicans isolates. However, this effect is dependent on FAR concentrations.

650    _2

$a ABC transportéry $x metabolismus $7 D018528

650    _2

$a antifungální látky $x farmakologie $7 D000935

650    _2

$a biologický transport $x účinky léků $7 D001692

650    _2

$a Candida albicans $x účinky léků $x metabolismus $7 D002176

650    _2

$a fungální léková rezistence $x účinky léků $7 D025141

650    _2

$a farnesol $x farmakologie $7 D005204

650    _2

$a flukonazol $x farmakologie $7 D015725

650    _2

$a fungální proteiny $x metabolismus $7 D005656

650    _2

$a membránové transportní proteiny $x metabolismus $7 D026901

650    _2

$a mikrobiální testy citlivosti $x metody $7 D008826

655    _2

$a časopisecké články $7 D016428

700    1_

$a Dižová, Stanislava $u 1 Department of Microbiology and Virology, Faculty of Natural Sciences, Comenius University in Bratislava, Bratislava, Slovakia.

700    1_

$a Gášková, Dana $u 2 Faculty of Mathematics and Physics, Institute of Physics, Charles University, Prague, Czech Republic.

700    1_

$a Jančíková, Iva $u 2 Faculty of Mathematics and Physics, Institute of Physics, Charles University, Prague, Czech Republic.

700    1_

$a Bujdáková, Helena $u 1 Department of Microbiology and Virology, Faculty of Natural Sciences, Comenius University in Bratislava, Bratislava, Slovakia.

773    0_

$w MED00008749 $t Microbial drug resistance (Larchmont, N.Y.) $x 1931-8448 $g Roč. 25, č. 6 (2019), s. 805-812

856    41

$u https://pubmed.ncbi.nlm.nih.gov/30785845 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20200109 $b ABA008

991    __

$a 20200115131723 $b ABA008

999    __

$a ok $b bmc $g 1483252 $s 1083656

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2019 $b 25 $c 6 $d 805-812 $e 20190220 $i 1931-8448 $m Microbial drug resistance $n Microb Drug Resist $x MED00008749

LZP    __

$a Pubmed-20200109